<DOC>
<DOCNO>
EP-0001333
</DOCNO>
<TEXT>
<DATE>
19790404
</DATE>
<IPC-CLASSIFICATIONS>
C07D-503/00 C07D-205/085 A61P-31/00 C07C-271/00 A61K-31/545 <main>C07D-498/04</main> A61K-31/43 C07C-271/22 A61K-31/42 C07D-205/00 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
beecham group ltdgb <sep>beecham group limited<sep>beecham group plc beecham house, great west road brentford, middlesex tw8 9bd gb<sep>beecham group plc<sep>
</APPLICANT>
<INVENTOR>
howarth thomas trefor<sep>hunt eric<sep>howarth, thomas trefor<sep>hunt, eric<sep>howarth, thomas trefor22 downswood carlton roadreigate surreygb<sep>hunt, eric10 the avenuebrockham betchworth surreygb<sep>howarth, thomas trefor<sep>hunt, eric<sep>howarth, thomas trefor22 downswood carlton roadreigate surreygb<sep>hunt, eric10 the avenuebrockham betchworth surreygb<sep>
</INVENTOR>
<ABSTRACT>
this invention provides the compounds of the formula  (i):    and salts and esters thereof, wherein r₁ is a hydrogen atom or  a lower alkyl, aryl or aralkyl group, r₂ and r₃ are independently  hydrogen, aryl, aralkyl, lower alkyl or substituted lower  alkyl, or r₃ is joined to r₁ to form a 4-, 5-, or 6- membered ring  or is joined to r₂ to form a 5- or 6- membered ring.  the compounds have β-lactamase inhibitory and antibacterial  properties.  the invention also provides a process for their preparation,  and pharmaceutical compositions containing them.  
</ABSTRACT>
</TEXT>
</DOC>
